RenBio’s Post

RenBio reposted this

View profile for Rachel Liberatore, PhD, graphic

President & Chief Scientific Officer at RenBio | Virology, Immunology, & Gene Transfer | Bicycle Commuter

Looking forward to a great meeting.

View organization page for hubXchange, graphic

1,740 followers

🚀 Register for our Antibody Therapeutics Xchange, where collaboration leads to innovation: https://lnkd.in/eUqXWGMe   Secure your spot at intimate roundtable discussions with industry leading facilitators: - Joe Zhao, Vice President, Head of External Innovation, Nona BiosciencesJulia Su, Ph.D., Associate Director, Protein Sciences, WuXi Biologics - Paul Royle, Technical Sales Manager Custom Antibodies, Bio-Rad LaboratoriesJ. Stewart New, Associate Director Antibody Discovery, IncyteShuji Sato, Senior Director of Client Relations, IPA (ImmunoPrecise Antibodies) - Seah Lim, Chief Executive Officer, Medicovestor, Inc. - Mark Tornetta, VP of Biologics Discovery, Tavotek Biotherapeutics - Mark Chiu, President, Tavotek BiotherapeuticsDylan Brethour, Senior Account Manager, evitria AG - Elisabeth K. Nyakatura, Ph.D., Senior Associate Director, Antibody Engineering, Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.Rachel Liberatore, PhD, President & Chief Scientific Officer, RenBio - Anthony Stajduhar, Director Business Development, Rapid Novor - Vladimir Jankovic, Head, Translational and Precision Medicine, Immuno-Oncology, Teva Pharmaceuticals   #hubXchange #antibodies #antibodydiscovery #antibodyengineering #bispecifics #targetselection #leadidentification #antibodyoptimization

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics